Renal Autologous Cell Therapy (REACT/ rilparencel)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseaseNCT05099770ProkidneyPhase 3Active not recruiting2029-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.